Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

INCYTE CORPORATION

(INCY)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
 SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Most relevant news about INCYTE CORPORATION
05/12INCYTE  : Data From Incyte's Oncology Portfolio Accepted for Presentation at the..
BU
05/12INCYTE  : MorphoSys Dose First Patient in Late-Stage Study of Lymphoma Drug Cand..
MT
05/10INCYTE  : Crescendo Biologics Names Incyte VP as Chief Financial Officer
MT
05/04INCYTE  : Swings to Q1 Profit, Revenue Rises
MT
05/04INCYTE : Q1 Earnings Snapshot
AQ
05/04INCYTE  : Reports 2021 First Quarter Financial Results and Provides Updates on K..
BU
05/04INCYTE  : Earnings Flash (INCY) INCYTE Reports Q1 EPS $0.67, vs. Street Est of $..
MT
05/04INCYTE CORPORATION  : 1st quarter results
CO
05/04INCYTE CORPORATION  : SEC Filing 10Q-1
CO
05/04INCYTE CORPORATION  : SEC Filing 8K
CO
05/03INCYTE  : Announces Data on Ruxolitinib Cream in Atopic Dermatitis Accepted for ..
BU
04/29EMA to quickly review Eli Lilly, Incyte arthritis drug for COVID-19 use
RE
04/27INCYTE  : to Present at Upcoming Investor Conference
BU
04/23INCYTE  : Announces New Findings from a Randomized Phase 2 Study of Ruxolitinib ..
BU
04/23INCYTE  : Announces New Findings from Pooled Analyses of the Phase 3 TRuE-AD Pro..
BU
More most relevant news
All news about INCYTE CORPORATION
05/12INCYTE  : Data From Incyte's Oncology Portfolio Accepted for Presentation at the..
BU
05/12INCYTE  : MorphoSys Dose First Patient in Late-Stage Study of Lymphoma Drug Cand..
MT
05/11PRESS RELEASE  : MorphoSys and Incyte Announce -3-
DJ
05/11PRESS RELEASE  : MorphoSys and Incyte Announce -2-
DJ
05/11PRESS RELEASE  : MorphoSys and Incyte Announce First Patient Dosed in Phase 3 fr..
DJ
05/10INCYTE  : Crescendo Biologics Names Incyte VP as Chief Financial Officer
MT
05/05PRESS RELEASE : MorphoSys AG Reports First Quarter -2-
DJ
05/05PRESS RELEASE : MorphoSys AG Reports First Quarter 2021 Results
DJ
05/04INCYTE  : Management's Discussion and Analysis of Financial Condition and Result..
AQ
05/04INCYTE  : Swings to Q1 Profit, Revenue Rises
MT
More news
News in other languages on INCYTE CORPORATION
05/13INCYTE  : Daten aus dem Onkologieportfolio von Incyte für Präsentation auf dem v..
05/13INCYTE  : Données du portefeuille d'oncologie d'Incyte acceptées pour présentati..
05/11DGAP-NEWS  : MorphoSys und Incyte geben die -3-
05/11DGAP-NEWS  : MorphoSys und Incyte geben die -2-
05/11DGAP-NEWS  : MorphoSys und Incyte geben die Dosierung des ersten Patienten in de..
05/06Morphosys schreibt Verlust und bestätigt Prognose
05/05DGAP-NEWS : MorphoSys AG berichtet über die -2-
05/05Wall Street : le Dow Jones in extremis dans le vert
05/04WallStreet : le Dow Jones sauve le 'par', Nasdaq chute encore
04/21Wall Street : consolide mais limite largement la casse
More news
Analyst Recommendations on INCYTE CORPORATION
04/19INCYTE  : Credit Suisse Adjusts Incyte's Price Target to $95 from $97, Keeps Neu..
MT
04/05INCYTE  : Morgan Stanley Adjusts Price Target on Incyte to $86 From $93, Maintai..
MT
02/10INCYTE  : Morgan Stanley Adjusts Incyte's Price Target to $93 From $97, Keeps Eq..
MT
02/10INCYTE  : SVB Leerink Downgrades Incyte to Underperform From Market Perform; Pri..
MT
02/10INCYTE  : RBC Capital Adjusts Incyte's Price Target to $93 From $89, Maintains S..
MT
More recommendations
Press releases
05/12INCYTE  : Data From Incyte's Oncology Portfolio Accepted for Presentation at the..
BU
05/04INCYTE  : Management's Discussion and Analysis of Financial Condition and Result..
AQ
05/04INCYTE : Q1 Earnings Snapshot
AQ
05/04INCYTE CORP  : Results of Operations and Financial Condition, Financial Statemen..
AQ
05/04INCYTE  : Reports 2021 First Quarter Financial Results and Provides Updates on K..
BU
More press releases
Official Publications
05/04Press Release 
05/041st quarter results 
05/04SEC Filing 10Q-1 
05/04SEC Filing 8K 
04/23Report 
04/09Report 
Upcoming event on INCYTE CORPORATION